Hexagon Capital Partners’s Intuitive Surgical ISRG Stock Holding History

Hexagon Capital Partners’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15	Closed	-$7.43K	–	884
2025 Q1	$7.43K	Buy	15 +2	+15%	+$1.11K	﹤0.01%	1061
2024 Q4	$6.79K	Buy	13 +8	+160%	+$4.17K	﹤0.01%	1126
2024 Q3	$2.46K	Buy	+5	New	+$2.33K	﹤0.01%	1188
2023 Q2	–	Sell	-69	Closed	-$17.6K	–	1461
2023 Q1	$17.6K	Hold	69	–	–	﹤0.01%	591
2022 Q4	$18.3K	Hold	69	–	–	0.01%	568
2022 Q3	$13K	Hold	69	–	–	﹤0.01%	697
2022 Q2	$14K	Hold	69	–	–	﹤0.01%	604
2022 Q1	$21K	Hold	69	–	–	0.01%	507
2021 Q4	$25K	Hold	69	–	–	0.01%	474
2021 Q3	$23K	Hold	69	–	–	0.01%	470
2021 Q2	$21K	Hold	69	–	–	0.01%	464
2021 Q1	$16K	Hold	69	–	–	﹤0.01%	466
2020 Q4	$18K	Hold	69	–	–	0.01%	398
2020 Q3	$15K	Buy	+69	New	+$15.5K	﹤0.01%	401

Other funds holding ISRG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $134M AUM 21.11% 1-Year Est. Return

Hexagon Capital Partners's ISRG Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Intuitive Surgical (ISRG) in Q2 2025, closing a stake of 15 shares — an estimated $7.43K sold.

Hexagon Capital Partners first reported a position in ISRG in Q3 2020 and held it in 14 quarters. The position peaked at $25K in Q4 2021. 2,265 funds tracked by Wall St. Rank hold ISRG as of Q2 2025.

Hexagon Capital Partners reported no remaining Intuitive Surgical position as of Q2 2025 after selling out during the quarter.
Hexagon Capital Partners sold 15 Intuitive Surgical shares in Q2 2025, an estimated $7.43K.
Hexagon Capital Partners first reported a position in Intuitive Surgical in Q3 2020 and held it in 14 quarters.
Hexagon Capital Partners's Intuitive Surgical position peaked at $25K in Q4 2021.
2,265 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.